Literature DB >> 32721653

Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern.

Fujun Yang1, Zhengwei Dong2, Yingran Shen1, Jinghan Shi1, Yulin Wu3, Zhipeng Zhao4, Gening Jiang5, Xiao Song6.   

Abstract

The predictive value of prognosis based on the histopathological subtype is a critical criterion in the new classification of lung adenocarcinoma published in 2011 by the International Association for the Study of Lung Cancer (IASLC), the American Thoracic Society (ATS), and the European Respiratory Society (ERS) (IASLC/ATS/ERS). In this new classification, the differences of histopathology and prognosis are two considerable parameters to classify the subtypes of lung adenocarcinoma. Cribriform growth pattern is regarded as a variant of acinar growth pattern in lung adenocarcinoma, however, more and more studies pointed out that cribriform growth pattern is associated with more aggressive histopathological structures, higher proportion of recurrence rates, and shorter postoperative survival than acinar growth pattern. These features are similar to solid or micropapillary predominant adenocarcinoma. In this review, we summarized the clinicopathological features, prognosis, and genetic variations of cribriform growth pattern of lung adenocarcinoma, and provided a novel insight into the diagnosis and treatment of cribriform lung adenocarcinoma.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clinicopathological features; Cribriform lung adenocarcinoma; Genetic variations; Prognosis

Mesh:

Year:  2020        PMID: 32721653     DOI: 10.1016/j.lungcan.2020.07.021

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

1.  Intercellular Communication-Related Molecular Subtypes and a Gene Signature Identified by the Single-Cell RNA Sequencing Combined with a Transcriptomic Analysis.

Authors:  Pin Guan; Wentao Cai; Ke Wu; Fan Jiang; Jinchan Wu; Xin Zhai; Min Zeng
Journal:  Dis Markers       Date:  2022-05-16       Impact factor: 3.464

2.  YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma.

Authors:  Qiang Xie; Shilei Zhao; Wenzhi Liu; Yanwei Cui; Fengzhou Li; Zhuoshi Li; Tao Guo; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

3.  Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma.

Authors:  Jinsong Bai; Chaoqiang Deng; Qiang Zheng; Di Li; Fangqiu Fu; Yuan Li; Yang Zhang; Haiquan Chen
Journal:  Transl Lung Cancer Res       Date:  2022-07

Review 4.  [A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].

Authors:  Chen Shen; Wentao Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-08-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.